Domov › Ulcerózna kolitída › Illinois › Chicago
Klinické štúdie Ulcerózna kolitída v meste Chicago, IL
15 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v meste Chicago a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Prebieha náborFáza 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Prebieha náborFáza 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Prebieha náborFáza 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Prebieha náborFáza 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Prebieha náborFáza 2
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Prebieha náborFáza 2
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Prebieha náborFáza 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Prebieha nábor
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Prebieha náborObservačná štúdia
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Prebieha náborFáza 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Prebieha náborFáza 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Prebieha nábor
- University of Chicago, Chicago
Štúdie Ulcerózna kolitída v iných mestách
- New York City, NY23 štúdií
- Orlando, FL22 štúdií
- Miami, FL21 štúdií
- Houston, TX17 štúdií
- San Antonio, TX16 štúdií
- Tacoma, WA15 štúdií
- San Diego, CA15 štúdií
- Tyler, TX14 štúdií
- Colorado Springs, CO14 štúdií
- Los Angeles, CA13 štúdií
- St. Louis, MO13 štúdií
- Washington, DC12 štúdií
Iné štúdie v Chicago
- Nemalobunkový karcinóm pľúc61 štúdií
- Rakovina prsníka58 štúdií
- Rakovina (všetky typy)51 štúdií
- Metastatická rakovina45 štúdií
- Rakovina prostaty45 štúdií
- Obézita41 štúdií
- Rakovina pľúc41 štúdií
- Rakovina vaječníkov36 štúdií
- Cievna mozgová príhoda34 štúdií
- Kolorektálny karcinóm33 štúdií
- Srdcové zlyhanie31 štúdií
- Nadváha28 štúdií
Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.